Journal article
Cost Effectiveness in Canada of a Multidrug Prepackaged Regimen (Hp-PAC®) for Helicobacter pylori Eradication
Abstract
Objective: To assess the cost effectiveness of a multidrug prepackaged regimen for Helicobacter pylori, the Hp-PAC® (lansoprazole 30mg, clarithromycin 500mg, amoxicillin 1g, all twice daily), relative to alternative pharmacological strategies in the management of confirmed duodenal ulcer over a 1-year period from 2 perspectives: (i) a strict healthcare payer perspective (Ontario Ministry ofHealth) excluding the patient copayment; and (ii) a …
Authors
Agro K; Blackhouse G; Goeree R; Willan AR; Huang J-Q; Hunt RH; O’Brien BJ
Journal
PharmacoEconomics, Vol. 19, No. 8, pp. 831–843
Publisher
Springer Nature
Publication Date
August 2001
DOI
10.2165/00019053-200119080-00005
ISSN
1170-7690